Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
ConditionSolid Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorNational Cancer Centre, Singapore
About this trial
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.
Eligibility criteria
Qualifiers
Confirmed histological diagnosis of solid tumor
Suitable for systematic treatment and clinical trials
ECOG (Eastern cooperative oncology group) performance status < 2
Able to provide tumor tissue for molecular profiling
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
5,500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov